乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Meeting Coverage >

Psych Congress

<乌鸦传媒>No Weird Dreams for Insomnia Patients Taking Lemborexant

Even at 10 mg, the sleep aid resulted in few abnormal dreams or nightmares

<乌鸦传媒>Trazodone Commonly Used Off-Label for Insomnia

Not much data to support efficacy or safety "as a surrogate hypnotic medication," researcher says

<乌鸦传媒>Rexulti Calms Alzheimer's Dementia-Related Agitation

But atypical antipsychotic disappoints in borderline personality disorder

<乌鸦传媒>Novel Combo for Schizophrenia Succeeds in Phase III Trial

Xanomeline-trospium has potential to be first-in-class therapy for schizophrenia if approved

<乌鸦传媒>Improvements in Treatment-Resistant Depression With Esketamine

Pooled data from randomized trials showed better scores on the PHQ-9 as well

<乌鸦传媒>Lemborexant Helps Insomniacs Catch More Z's

Even patients with history of depression had better sleep outcomes

<乌鸦传媒>Novel Oral Antidepressant Shows Rapid Symptom Improvement

Improvement with 50-mg zuranolone seen by day 3

<乌鸦传媒>Is Earlier Use of Long-Acting Injectable Drugs for Schizophrenia Better?

Early use linked to fewer inpatient stays and ER visits, study finds

<乌鸦传媒>Extended-Release Risperidone Injectable Staves Off Schizophrenia Relapse

Phase III RISE study found benefit with both once-monthly and bimonthly dose

<乌鸦传媒>COVID Doesn't Dampen LAI Antipsychotic Prescribing in Schizophrenia

Survey study shows no major changes in prescription trends in 2020

<乌鸦传媒>Migraine Drug Shows Benefit for Those With Comorbid Depression, Anxiety

Real-world study of fremanezumab found that patients were able to reduce antidepressant use

<乌鸦传媒>Antipsychotic Patch Quiets Schizophrenia-Related Hostility

Most significant improvement seen with highest asenapine transdermal dose

<乌鸦传媒>Psych Congress 2020: Notable Studies

Research highlights from the virtual meeting

<乌鸦传媒>Trial: Drug Induces, Maintains Dementia-Related Psychosis Remission

Results pave way for Nuplazid label expansion

<乌鸦传媒>Long-Term Gains with Austedo in Tardive Dyskinesia

Most robust improvement seen in people with more severe disease

<乌鸦传媒>Lemborexant Boosts Sleep Outcomes in Insomnia

SUNRISE 2 trial shows better sleep onset, maintenance, and quality

<乌鸦传媒>Schizophrenia Tx Eases Depression in Bipolar Disorder

Lumateperone offers greater rate of response, remission versus placebo

<乌鸦传媒>Abuse-Deterrent Amphetamine Shines for Adult ADHD

AR19 formulated with physical and chemical barriers against misuse

<乌鸦传媒>Add-On Nuplazid Gets a Win in Early Schizophrenia Trial

Phase II study met primary efficacy endpoint

<乌鸦传媒>Oral Postpartum Depression Drug Reduces Symptoms for New Moms

Interestingly, drug flopped in a trial last year for major depressive disorder

<乌鸦传媒>Overweight Patients Less Likely to Gain Weight on Antipsychotic

Analysis looked at users of brexpiprazole (Rexulti)

<乌鸦传媒>Esketamine Nasal Spray Reduces Depression in Suicidal Patients

Positive results from first global registration program of patients with active suicidal ideation, intent

<乌鸦传媒>Novel Combo Tx Shows Durable Antipsychotic Effects

Almost half of patients with schizophrenia deemed PANSS responders with samidorphan/olanzapine

<乌鸦传媒>PM Stimulant Eases Daily Life for Kids With ADHD

Parent-reported outcomes positive with delayed- and extended-release methylphenidate

<乌鸦传媒>Injectable vs Oral Antipsychotics: Patients Have Preferences

Long-acting injectables generally endorsed, but some still favor daily pills